Comparative Assessment of Phytochemical Profiles in Tissue Culture-raised, Field-raised, and Commercial Extract of

The medicinal efficacy of Bacopa monnieri (L.) Wettst. is closely linked to its diverse secondary metabolites, including phenolics, flavonoids, and alkaloids, though commercial use is limited by phytochemical variability in wild and cultivated plants. This study comparatively evaluated phytochemical profiles of tissue culture-raised plants, field-grown counterparts, and standardized commercial extracts (used as a reference sample for comparative assessment of metabolite concentrations relative to raw plant sources) using systematic qualitative screening and quantitative estimation. Total phenolics, flavonoids, and alkaloids were quantified using Folin-Ciocalteu, aluminium chloride, and BCG-chloroform assays, respectively. The study demonstrates that extracts obtained from in-vitro raised plants exhibited approximately 2.40-fold higher total phenolic content, and 1.48-fold higher alkaloid content compared to the field-raised samples, along with a slight increase (~1.04-fold and ~1.62 fold, respectively) over commercial product. Although the commercial sample showed highest flavonoid content, tissue culture-raised extract still demonstrated a ~3.22-fold higher flavonoid concentration compared to field-raised plant extract. Therefore, this result aims to elucidate the inconsistencies in metabolite accumulation across different production systems and evaluate whether biotechnological interventions through plant tissue culture provide more consistent and enriched source of secondary metabolites compared to traditional field cultivated and processed commercial products.